Gene · 4507
Papers2,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Grade Astrocytoma With Piloid Features: An Aggressive Clinicogenomic Entity Distinct From Pilocytic Astrocytoma. | J Korean Med Sci | 2026 | 41807027 | PubTator, text mining | PubMed |
| Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas. | J Neuropathol Exp Neurol | 2026 | 41802222 | PubTator, text mining | PubMed |
| Immunometabolism in lung cancer - The link between metabolism and immune response. | iScience | 2026 | 41797927 | PubTator, text mining | PubMed |
| ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib. | Cancer Discov | 2026 | 41790042 | PubTator, text mining | PubMed |
| IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors. | J Clin Invest | 2026 | 41766654 | PubTator, text mining | PubMed |
| Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities. | Front Cell Dev Biol | 2026 | 41756674 | PubTator, text mining | PubMed |
| A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer. | Antioxidants (Basel) | 2026 | 41750579 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. | Biomolecules | 2026 | 41750326 | PubTator, text mining | PubMed |
| Clinical Importance of Molecular Biomarkers in Pleural Mesothelioma. | Cancers (Basel) | 2026 | 41749932 | PubTator, text mining | PubMed |
| PScnv: personalized self-normalizing CNV detection with a hierarchical multi-phase framework. | Bioinformatics | 2026 | 41746294 | PubTator, text mining | PubMed |
| Predictors of Response and Mechanisms of Resistance to Antibody Drug Conjugates in Urothelial Carcinoma. | Curr Oncol | 2026 | 41744867 | PubTator, text mining | PubMed |
| Journey of Methionine Adenosyltransferase 2A Inhibitors: From Bench to Advanced Clinical Trials. | J Med Chem | 2026 | 41738461 | PubTator, text mining | PubMed |
| Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory Myofibroblastic Tumor. | Mod Pathol | 2026 | 41730366 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| ALK Inhibitor Response in Novel ZFPM2::ALK and TRIM24::ALK Fusion-Positive Lung Cancers: Case Report. | JTO Clin Res Rep | 2026 | 41717049 | PubTator, text mining | PubMed |
| Jejunal Metastasis from Malignant Pleural Mesothelioma during Long-Term Nivolumab Therapy: A Case Report and Literature Review. | Surg Case Rep | 2026 | 41716210 | PubTator, text mining | PubMed |
| Shaping death: how the microbiome regulates tumour cell demise and therapy response. | Cancer Metastasis Rev | 2026 | 41714812 | PubTator, text mining | PubMed |
| High KAP1 expression promotes pleural mesothelioma cell proliferation and metastasis. | Int J Biol Markers | 2026 | 41712373 | PubTator, text mining | PubMed |
| Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank. | J Neurooncol | 2026 | 41712020 | PubTator, text mining | PubMed |
| Methionine restriction in cancer: a dietary insight for therapy. | Front Nutr | 2026 | 41710278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4507/papers?page=7